Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

August 19, 2020

Study Completion Date

August 19, 2020

Conditions

Lateral Canthal Lines

Interventions

DRUG

MBA-P01(Botulinum toxin A)

Intramuscular injection; Dose varies by group

DRUG

Placebo

Intramuscular injection; normal saline

Trial Locations (1)

Maroubra Medical Centre, Maroubra

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT04143854 - Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines | Biotech Hunter | Biotech Hunter